This data comes from the presentation, “Radiation Enhances Anti-Tumor Activity of Checkpoint Blockade in Syngeneic Tumor Models” by Covance researchers Sumithra Urs, Mary Anne Meade, Kevin Guley, Sarah Krueger, Alden Wong, Scott Wise, and Maryland Rosenfeld Franklin. SARRP enables researchers to perform targeted focal irradiation, allowing researchers to evaluate radiation therapy efficacy alone and with immunomodulatory therapies.
See the original presentation here.
Contact Us
Accurate dosimetry and reporting is the best practice in radiation research. While systems like the Xstrahl CIX series have been established as both reproducible and accurate, determining the exact dose delivered to a subject can be difficult due to the interactions...
Xstrahl in Action Researchers developed guidance on how and what to report in regard to dosimetry in radiation research.Publication Minimum reporting standards should be expected for preclinical radiobiology irradiators and dosimetryAuthors François Trompier, Larry A....
Xstrahl in Action A recent study aimed to characterize a detection system based on inorganic scintillators and determine its suitability for dosimetry in preclinical radiation research, using our Small Animal Radiation Research Platform (SARRP).Publication...
